Free Trial

Ginkgo Bioworks (DNA) to Release Earnings on Tuesday

Ginkgo Bioworks logo with Medical background

Ginkgo Bioworks (NYSE:DNA - Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Ginkgo Bioworks to post earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.

Ginkgo Bioworks Trading Down 5.0 %

Shares of Ginkgo Bioworks stock traded down $0.58 during trading hours on Friday, reaching $10.86. 2,027,060 shares of the company's stock were exchanged, compared to its average volume of 1,691,831. The business's 50 day moving average is $11.45. Ginkgo Bioworks has a fifty-two week low of $5.26 and a fifty-two week high of $64.40. The firm has a market cap of $623.95 million, a PE ratio of -0.83 and a beta of 1.16.

About Ginkgo Bioworks

(Get Free Report)

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

See Also

Earnings History for Ginkgo Bioworks (NYSE:DNA)

Should You Invest $1,000 in Ginkgo Bioworks Right Now?

Before you consider Ginkgo Bioworks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ginkgo Bioworks wasn't on the list.

While Ginkgo Bioworks currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines